Compass Therapeutics Inc (CMPX)
1.9300 -0.0100 (-0.52%) 13:10 ET [NASDAQ]
1.9300 x 400 1.9400 x 1,100
Realtime by (Cboe BZX)
1.9300 x 400 1.9400 x 1,100
Realtime 1.9300 -0.0100 (-0.52%) 08:41 ET
for Mon, Apr 28th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -49,375 | -42,494 | -39,225 | -82,181 | -29,500 |
| Depreciation Amortization | 102 | -1,336 | 1,103 | 1,624 | 2,404 |
| Accounts payable and accrued liabilities | -1,841 | 708 | 2,515 | -194 | 432 |
| Other Working Capital | -4,142 | -2,908 | -1,263 | 6,245 | -4,650 |
| Other Operating Activity | 10,401 | 5,412 | 2,745 | 54,840 | 4,511 |
| Operating Cash Flow | $-44,855 | $-40,618 | $-34,125 | $-19,666 | $-26,803 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 46,816 | 26,995 | -151,164 | N/A | N/A |
| PPE Investments | -44 | -30 | -36 | -1,452 | 38 |
| Net Acquisitions | N/A | N/A | N/A | -318 | N/A |
| Investing Cash Flow | $46,772 | $26,965 | $-151,200 | $-1,770 | $38 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -9,375 | -5,625 |
| Common Stock Issued | 18,113 | 3,188 | 76,252 | 128,267 | 60,482 |
| Common Stock Repurchased | -543 | -94 | -495 | -281 | -6,319 |
| Other Financing Activity | -232 | -159 | 0 | 0 | 0 |
| Financing Cash Flow | $17,338 | $2,935 | $75,757 | $118,611 | $48,538 |
| Beginning Cash Position | 24,228 | 34,946 | 144,514 | 47,339 | 25,566 |
| End Cash Position | 43,483 | 24,228 | 34,946 | 144,514 | 47,339 |
| Net Cash Flow | $19,255 | $-10,718 | $-109,568 | $97,175 | $21,773 |
| Free Cash Flow | |||||
| Operating Cash Flow | -44,855 | -40,618 | -34,125 | -19,666 | -26,803 |
| Capital Expenditure | -44 | -30 | -212 | -1,568 | -106 |
| Free Cash Flow | -44,899 | -40,648 | -34,337 | -21,234 | -26,909 |